These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21182596)

  • 101. Angiopoietin-like proteins: a comprehensive look.
    Santulli G
    Front Endocrinol (Lausanne); 2014; 5():4. PubMed ID: 24478758
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Angiopoietin-like proteins 3, 4 and 8: regulating lipid metabolism and providing new hope for metabolic syndrome.
    Li Y; Teng C
    J Drug Target; 2014 Sep; 22(8):679-87. PubMed ID: 24960069
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Regulation of triglyceride metabolism by Angiopoietin-like proteins.
    Mattijssen F; Kersten S
    Biochim Biophys Acta; 2012 May; 1821(5):782-9. PubMed ID: 22063269
    [TBL] [Abstract][Full Text] [Related]  

  • 104. The angiopoietin-like protein 3: a hepatokine with expanding role in metabolism.
    Arca M; Minicocci I; Maranghi M
    Curr Opin Lipidol; 2013 Aug; 24(4):313-20. PubMed ID: 23839332
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes.
    Dijk W; Beigneux AP; Larsson M; Bensadoun A; Young SG; Kersten S
    J Lipid Res; 2016 Sep; 57(9):1670-83. PubMed ID: 27034464
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome.
    Abu-Farha M; Abubaker J; Al-Khairi I; Cherian P; Noronha F; Kavalakatt S; Khadir A; Behbehani K; Alarouj M; Bennakhi A; Elkum N
    Cardiovasc Diabetol; 2016 Feb; 15():25. PubMed ID: 26850725
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The role of ANGPTL3 in controlling lipoprotein metabolism.
    Tikka A; Jauhiainen M
    Endocrine; 2016 May; 52(2):187-93. PubMed ID: 26754661
    [TBL] [Abstract][Full Text] [Related]  

  • 108. A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy.
    Zhang R; Abou-Samra AB
    Cardiovasc Diabetol; 2014 Sep; 13():133. PubMed ID: 25212743
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Relationship between serum levels of angiopoietin-related growth factor and metabolic risk factors.
    Ebert T; Kralisch S; Loessner U; Jessnitzer B; Stumvoll M; Fasshauer M; Tönjes A
    Horm Metab Res; 2014 Sep; 46(10):685-90. PubMed ID: 25011017
    [TBL] [Abstract][Full Text] [Related]  

  • 110. ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling.
    Masuda T; Endo M; Yamamoto Y; Odagiri H; Kadomatsu T; Nakamura T; Tanoue H; Ito H; Yugami M; Miyata K; Morinaga J; Horiguchi H; Motokawa I; Terada K; Morioka MS; Manabe I; Iwase H; Mizuta H; Oike Y
    Sci Rep; 2015 Mar; 5():9170. PubMed ID: 25773070
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation.
    Flehmig G; Scholz M; Klöting N; Fasshauer M; Tönjes A; Stumvoll M; Youn BS; Blüher M
    PLoS One; 2014; 9(6):e99785. PubMed ID: 24968098
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation.
    Abu-Farha M; Ghosh A; Al-Khairi I; Madiraju SRM; Abubaker J; Prentki M
    Prog Lipid Res; 2020 Nov; 80():101067. PubMed ID: 33011191
    [TBL] [Abstract][Full Text] [Related]  

  • 113. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.
    Chi X; Britt EC; Shows HW; Hjelmaas AJ; Shetty SK; Cushing EM; Li W; Dou A; Zhang R; Davies BSJ
    Mol Metab; 2017 Oct; 6(10):1137-1149. PubMed ID: 29031715
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Angiopoietin-like 3 in lipoprotein metabolism.
    Kersten S
    Nat Rev Endocrinol; 2017 Dec; 13(12):731-739. PubMed ID: 28984319
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Inhibition of angiogenesis and regenerative lung growth in
    Hunyenyiwa T; Kyi P; Scheer M; Joshi M; Gasparri M; Mammoto T; Mammoto A
    Front Cardiovasc Med; 2024; 11():1491971. PubMed ID: 39479393
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Exploration and Validation of Immune and Therapeutic-Related Hub Genes in Aortic Valve Calcification and Carotid Atherosclerosis.
    Wei K; Cao Y; Kong X; Liu C; Gu X
    J Inflamm Res; 2024; 17():6485-6500. PubMed ID: 39310903
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Sexual Dimorphism's impact on adipogenesis: A three-dimensional in vitro model treated with 17β-estradiol and testosterone.
    Pal P; Maranon RO; Rivera Gonzales OJ; Speed JS; Janorkar AV
    Mol Cell Endocrinol; 2024 Aug; 589():112249. PubMed ID: 38604550
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Role of the angiopoietin-like protein family in the progression of NAFLD.
    Su X; Xu Q; Li Z; Ren Y; Jiao Q; Wang L; Wang Y
    Heliyon; 2024 Apr; 10(7):e27739. PubMed ID: 38560164
    [TBL] [Abstract][Full Text] [Related]  

  • 119. The chylomicron saga: time to focus on postprandial metabolism.
    Gugliucci A
    Front Endocrinol (Lausanne); 2023; 14():1322869. PubMed ID: 38303975
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease.
    Mazidi M; Wright N; Yao P; Kartsonaki C; Millwood IY; Fry H; Said S; Pozarickij A; Pei P; Chen Y; Avery D; Du H; Schmidt DV; Yang L; Lv J; Yu C; Chen J; Hill M; Holmes MV; Howson JMM; Peto R; Collins R; Bennett DA; Walters RG; Li L; Clarke R; Chen Z;
    J Am Coll Cardiol; 2023 Nov; 82(20):1906-1920. PubMed ID: 37940228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.